SuperworthInMed Pharmaceuticals shares outstanding INM
Diluted shares outstanding, averaged over each quarter, from 2019.
- Latest quarter, to Jun 30, 2026
- 4.7M
- On a year earlier
- +214.7%
- more shares
InMed Pharmaceuticals had 4.7M diluted shares outstanding on average in Q4 FY26, the quarter to Jun 30, 2026.
That is 214.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 4.7M | +215% |
| FY2025 | 1.5M | +211% |
| FY2024 | 480.6K | +189% |
| FY2023 | 166.4K | +416% |
| FY2022 | 32.2K | +100% |
| FY2021 | 16.1K | +54% |
| FY2020 | 10.4K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY26 | 4.7M | +215% | |
| Q3 FY26 | 4M | +269% | |
| Q2 FY26 | 4M | +460% | |
| Q1 FY26 | 4M | +538% | |
| Q4 FY25 | 1.5M | +211% | |
| Q3 FY25 | 1.1M | +128% | |
| Q2 FY25 | 706.5K | +77% | |
| Q1 FY25 | 620.1K | +273% | |
| Q4 FY24 | 480.6K | +189% | |
| Q3 FY24 | 480.6K | +189% | |
| Q2 FY24 | 398.7K | +247% | |
| Q1 FY24 | 166.4K | +284% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on InMed Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.